Structures of 4-{3-(X-phenyl)perhydro-1,3-oxazolo[3,4-a]pyridin-1-yl}-2,8-bis(trifluoromethyl)quinolines (X = H, 2-O2N, 3-O2N and 4-O2N), derived from mefloquine

被引:8
作者
Goncalves, Raoni S. B. [2 ,3 ]
Kaiser, Carlos R. [3 ]
de Souza, Marcus V. N. [2 ]
Wardell, James L. [1 ]
Wardell, Solange M. S. V. [4 ]
Howie, R. Alan [5 ]
机构
[1] Fiocruz MS, CDTS, BR-21040900 Rio De Janeiro, Brazil
[2] Inst Tecnol Farmacos Far Manguinhos, FioCruz Fundacao Oswaldo Cruz, BR-21041250 Rio De Janeiro, Brazil
[3] Univ Fed Rio de Janeiro, Inst Quim, Dept Quim Organ, BR-21945970 Rio De Janeiro, Brazil
[4] CHEMSOL, Aberdeen AB15 5NY, Scotland
[5] Univ Aberdeen, Dept Chem, Old Aberdeen AB24 3UE, Scotland
来源
ZEITSCHRIFT FUR KRISTALLOGRAPHIE-CRYSTALLINE MATERIALS | 2011年 / 226卷 / 10期
关键词
Mefloquine derivatives; Hydrogen bonding; Intermolecular interactions; Single crystal structure analysis; X-ray diffraction; CRYSTAL-STRUCTURES; IN-VIVO; DERIVATIVES; FLUORINE; LIGANDS; DRUG;
D O I
10.1524/zkri.2011.1426
中图分类号
O7 [晶体学];
学科分类号
0702 ; 070205 ; 0703 ; 080501 ;
摘要
The crystal structures of four 4-{3-(X-phenyl)perhydro-1,3-oxazolo[3,4-a]pyridin-1-yl}-2,8-bis(trifluoromethyl)quinolines, (2: X = H, 2-O2N, 3-O2N and 4-O2N) are reported. Differences in the conformations of the molecules are illustrated by the angles between the best planes through the various ring moieties. There are no strong intermolecular interactions, such as O-H center dot center dot center dot O, present in any of the four compounds. Instead, present in each of the four compounds are different combinations of some of C-H center dot center dot center dot F, C-H center dot center dot center dot O(nitro), C-H center dot center dot center dot pi, C-F center dot center dot center dot pi, N-O center dot center dot center dot pi and pi center dot center dot center dot pi-stacking interactions, which result in very different supramolecular arrangements.
引用
收藏
页码:793 / 803
页数:11
相关论文
共 50 条
[1]   In vivo pharmacodynamics of a new oxazolidinone (linezolid) [J].
Andes, D ;
van Ogtrop, ML ;
Peng, J ;
Craig, WA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (11) :3484-3489
[2]  
[Anonymous], 2007, SADABS VERSION 2007
[3]  
[Anonymous], MERC 2 4
[5]   Organic fluorine compounds: a great opportunity for enhanced materials properties [J].
Berger, Ricarda ;
Resnati, Giuseppe ;
Metrangolo, Pierangelo ;
Weber, Edwin ;
Hulliger, Juerg .
CHEMICAL SOCIETY REVIEWS, 2011, 40 (07) :3496-3508
[6]   SRI-286, a thiosemicarbazole, in combination with mefloquine and moxifloxacin for treatment of murine Mycobacterium avium complex disease [J].
Bermudez, LE ;
Kolonoski, P ;
Seitz, LE ;
Petrofsky, M ;
Reynolds, R ;
Wu, M ;
Young, LS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (09) :3556-3558
[7]   Mefloquine is active in vitro and in vivo against Mycobacterium avium complex [J].
Bermudez, LE ;
Kolonoski, P ;
Wu, M ;
Aralar, PA ;
Inderlied, CB ;
Young, LS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (08) :1870-1874
[8]   PATTERNS IN HYDROGEN BONDING - FUNCTIONALITY AND GRAPH SET ANALYSIS IN CRYSTALS [J].
BERNSTEIN, J ;
DAVIS, RE ;
SHIMONI, L ;
CHANG, NL .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 1995, 34 (15) :1555-1573
[9]   Synthetic ferrocenic mefloquine and quinine analogues as potential antimalarial agents [J].
Biot, C ;
Delhaes, L ;
Maciejewski, LA ;
Mortuaire, M ;
Camus, D ;
Dive, D ;
Brocard, JS .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2000, 35 (7-8) :707-714
[10]  
Brammer L, 2001, CRYST GROWTH DES, V1, P277, DOI 10.1021/cg0l5522k